Mechanical thrombectomy in acute limb ischemia: ad Interim results of the INDIAN UP Trial.
Humans
Male
Middle Aged
Aged
Aged, 80 and over
Female
Indigo Carmine
Orlistat
Endovascular Procedures
/ adverse effects
Peripheral Arterial Disease
/ diagnostic imaging
Treatment Outcome
Ischemia
/ diagnostic imaging
Thrombectomy
/ adverse effects
Arterial Occlusive Diseases
/ surgery
Limb Salvage
Retrospective Studies
Vascular Patency
Lower Extremity
Journal
The Journal of cardiovascular surgery
ISSN: 1827-191X
Titre abrégé: J Cardiovasc Surg (Torino)
Pays: Italy
ID NLM: 0066127
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
medline:
2
6
2023
pubmed:
20
4
2023
entrez:
20
04
2023
Statut:
ppublish
Résumé
Penumbra/Indigo aspiration thrombectomy Systems (Penumbra Inc.) in patients with acute lower limb ischemia (ALLI) is becoming a fundamental alternative to surgical and intra-arterial thrombolysis. The INDIAN UP trial represents the second phase of the Italian national multicenter trial evaluating the safety and effectiveness of the device in the treatment of ALLI. To assess vessel patency, the TIPI (Thrombo-aspiration In Peripheral Ischemia), is used. The TIPI flow in three different moments: at presentation, immediately after thromboaspiration, and after all adjuvant procedures. The primary outcome is the technical success of the thrombo-aspiration with the investigative system, defined as near complete or complete revascularization TIPI 2 - 3. Safety and clinical success rate were collected at one month follow-up. A total of 250 patients were enrolled. The mean age was 72.2±13.1 years and 72.1% were male. Rutherford grade on enrolment was I in 10.8%, IIa in 34.9%, and IIb in 54.4%. Primary technical success (TIPI 2-3 flow) was achieved in 90.8% of patients. Adjunctive procedures were needed in 158 cases. After all interventions, assisted primary technical success was 96.4%. No systemic bleeding complications or device related serious adverse events were reported. At one month follow up, survival rate was 97.2%, limb salvage was 97.6%. Primary patency was 89.6% and 13 (5.4%) reinterventions were registered. The updated results of the INDIAN UP trial have confirmed the high value of the mechanical thromboaspiration device Indigo Penumbra in the treatment of ALLI in a large variety of clinical and anatomical settings.
Sections du résumé
BACKGROUND
BACKGROUND
Penumbra/Indigo aspiration thrombectomy Systems (Penumbra Inc.) in patients with acute lower limb ischemia (ALLI) is becoming a fundamental alternative to surgical and intra-arterial thrombolysis. The INDIAN UP trial represents the second phase of the Italian national multicenter trial evaluating the safety and effectiveness of the device in the treatment of ALLI.
METHODS
METHODS
To assess vessel patency, the TIPI (Thrombo-aspiration In Peripheral Ischemia), is used. The TIPI flow in three different moments: at presentation, immediately after thromboaspiration, and after all adjuvant procedures. The primary outcome is the technical success of the thrombo-aspiration with the investigative system, defined as near complete or complete revascularization TIPI 2 - 3. Safety and clinical success rate were collected at one month follow-up.
RESULTS
RESULTS
A total of 250 patients were enrolled. The mean age was 72.2±13.1 years and 72.1% were male. Rutherford grade on enrolment was I in 10.8%, IIa in 34.9%, and IIb in 54.4%. Primary technical success (TIPI 2-3 flow) was achieved in 90.8% of patients. Adjunctive procedures were needed in 158 cases. After all interventions, assisted primary technical success was 96.4%. No systemic bleeding complications or device related serious adverse events were reported. At one month follow up, survival rate was 97.2%, limb salvage was 97.6%. Primary patency was 89.6% and 13 (5.4%) reinterventions were registered.
CONCLUSIONS
CONCLUSIONS
The updated results of the INDIAN UP trial have confirmed the high value of the mechanical thromboaspiration device Indigo Penumbra in the treatment of ALLI in a large variety of clinical and anatomical settings.
Identifiants
pubmed: 37078985
pii: S0021-9509.23.12668-1
doi: 10.23736/S0021-9509.23.12668-1
doi:
Substances chimiques
Indigo Carmine
D3741U8K7L
Orlistat
95M8R751W8
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
247-254Investigateurs
Domenico Angiletta
(D)
Luca Boccalon
(L)
Andrea Boghi
(A)
Giulia Bonera
(G)
Pierluigi Cappiello
(P)
Nicola Cionfoli
(N)
Chiara Comelli
(C)
Riccardo Corti
(R)
Raffaele Cuomo
(R)
Mauro D'Agostino
(M)
Francesco DI Bartolomeo
(F)
Luca DI Maggio
(L)
Andrea Discalzi
(A)
Mario D'Oria
(M)
Andrea Esposito
(A)
Stefano Fazzini
(S)
Michelangelo Ferri
(M)
Andrea Gaggiano
(A)
Luca Garriboli
(L)
Tommaso Gorgatti
(T)
Giacomo Isernia
(G)
Antonio Lauricella
(A)
Giovanni Leati
(G)
Massimo Lenti
(M)
Sandro Lepidi
(S)
Andrea Mancini
(A)
Paola Manzo
(P)
Danilo Menna
(D)
Vincenzo Molinari
(V)
Lorenzo Moramarco
(L)
Giorgio Nocivelli
(G)
Gianbattista Parlani
(G)
Raffaele Pulli
(R)
Pietro Quaretti
(P)
Sonia Ronchey
(S)
Denis Rossato
(D)
Davide Santuari
(D)
Andrea Siani
(A)
Roberto Silingardi
(R)
Gioele Simonte
(G)
Pasqualino Sirignano
(P)
Francesco Speziale
(F)
Andrea Viazzo
(A)